Rankings
▼
Calendar
AQST Q3 2017 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$424M
Q3 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$27M
Gross Profit
$22M
82.0% margin
Operating Income
$10M
38.4% margin
Net Income
$8M
31.1% margin
EPS (Diluted)
$0.39
QoQ Revenue Growth
+143.6%
Cash Flow
Operating Cash Flow
$16M
Free Cash Flow
$15M
Stock-Based Comp.
$0
← FY 2017
All Quarters
Q4 2017 →
